These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12629123)

  • 21. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
    Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
    Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
    Wakatsuki A; Sagara Y
    Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
    Lobo RA; Bush T; Carr BR; Pickar JH
    Fertil Steril; 2001 Jul; 76(1):13-24. PubMed ID: 11438314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
    Hu P; Greendale GA; Palla SL; Reboussin BA; Herrington DM; Barrett-Connor E; Reuben DB
    Atherosclerosis; 2006 Apr; 185(2):347-52. PubMed ID: 16023653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy.
    Sullivan JM; Shala BA; Miller LA; Lerner JL; McBrayer JD
    Menopause; 2018 Nov; 25(11):1180-1186. PubMed ID: 30358710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
    Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia.
    Sanada M; Higashi Y; Nakagawa K; Kodama I; Tsuda M; Nagai N; Chayama K; Ohama K
    Maturitas; 2003 Apr; 44(4):307-15. PubMed ID: 12697372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Tsuda M; Nagai N; Ohama K
    J Am Coll Cardiol; 2001 May; 37(6):1529-35. PubMed ID: 11345361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
    Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
    Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women.
    Kazerooni T; Zolghadri J
    Gynecol Endocrinol; 2004 Aug; 19(2):64-8. PubMed ID: 15624267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time?
    Alper T; Cetinkaya MB; Kokcu A; Yanik FF; Malatyalioglu E
    Gynecol Endocrinol; 2004 Apr; 18(4):199-205. PubMed ID: 15293891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.